405 related articles for article (PubMed ID: 19062197)
21. Advances in ovarian cancer proteomics: the quest for biomarkers and improved therapeutic interventions.
Jurisicova A; Jurisica I; Kislinger T
Expert Rev Proteomics; 2008 Aug; 5(4):551-60. PubMed ID: 18761466
[TBL] [Abstract][Full Text] [Related]
22. Proteomic analysis of colorectal cancer: discovering novel biomarkers.
Skandarajah AR; Moritz RL; Tjandra JJ; Simpson RJ
Expert Rev Proteomics; 2005 Oct; 2(5):681-92. PubMed ID: 16209648
[TBL] [Abstract][Full Text] [Related]
23. Humoral immunity directed against tumor-associated antigens as potential biomarkers for the early diagnosis of cancer.
Lu H; Goodell V; Disis ML
J Proteome Res; 2008 Apr; 7(4):1388-94. PubMed ID: 18311901
[TBL] [Abstract][Full Text] [Related]
24. Tumor-associated antigens and biomarkers in cancer and immune therapy.
Malyankar UM
Int Rev Immunol; 2007; 26(3-4):223-47. PubMed ID: 17558745
[TBL] [Abstract][Full Text] [Related]
25. Genetic and epigenetic biomarkers in cancer diagnosis and identifying high risk populations.
Verma M; Manne U
Crit Rev Oncol Hematol; 2006 Oct; 60(1):9-18. PubMed ID: 16829121
[TBL] [Abstract][Full Text] [Related]
26. Beyond PSA: utility of novel tumor markers in the setting of elevated PSA.
Lin DW
Urol Oncol; 2009; 27(3):315-21. PubMed ID: 19414121
[TBL] [Abstract][Full Text] [Related]
27. MicroRNAs in clinical oncology: at the crossroads between promises and problems.
Metias SM; Lianidou E; Yousef GM
J Clin Pathol; 2009 Sep; 62(9):771-6. PubMed ID: 19734473
[TBL] [Abstract][Full Text] [Related]
28. [DNA methylation: potential for diagnosis, prognosis and therapy--prediction in oncology].
Haedicke W; Lesche R
Verh Dtsch Ges Pathol; 2006; 90():39-45. PubMed ID: 17867578
[TBL] [Abstract][Full Text] [Related]
29. [Molecular characterization of metastatic renal cell carcinomas. Differentiation of prognosis and therapy].
Junker K; Sanjmyatav J; Heinze C; Walter M; Heinzelmann J; Wunderlich H; Schubert J; Steiner T
Urologe A; 2008 Sep; 47(9):1187-9. PubMed ID: 18688592
[TBL] [Abstract][Full Text] [Related]
30. Biomarker profiling for cancer diagnosis, prognosis and therapeutic management.
Mitra AP; Lin H; Cote RJ; Datar RH
Natl Med J India; 2005; 18(6):304-12. PubMed ID: 16483031
[TBL] [Abstract][Full Text] [Related]
31. Proteins' promise--progress and challenges in ovarian cancer proteomics.
Koehn H; Oehler MK
Menopause Int; 2007 Dec; 13(4):148-53. PubMed ID: 18088525
[TBL] [Abstract][Full Text] [Related]
32. Large-scale proteomics analysis of human ovarian cancer for biomarkers.
Bengtsson S; Krogh M; Szigyarto CA; Uhlen M; Schedvins K; Silfverswärd C; Linder S; Auer G; Alaiya A; James P
J Proteome Res; 2007 Apr; 6(4):1440-50. PubMed ID: 17315909
[TBL] [Abstract][Full Text] [Related]
33. Possible common biomarkers from FTIR microspectroscopy of cervical cancer and melanoma.
Mordechai S; Sahu RK; Hammody Z; Mark S; Kantarovich K; Guterman H; Podshyvalov A; Goldstein J; Argov S
J Microsc; 2004 Jul; 215(Pt 1):86-91. PubMed ID: 15230879
[TBL] [Abstract][Full Text] [Related]
34. Detection of circulating tumor cells in bladder cancer patients.
Nezos A; Pissimisis N; Lembessis P; Sourla A; Dimopoulos P; Dimopoulos T; Tzelepis K; Koutsilieris M
Cancer Treat Rev; 2009 May; 35(3):272-9. PubMed ID: 19103472
[TBL] [Abstract][Full Text] [Related]
35. Moving cancer diagnostics from bench to bedside.
Zhang X; Li L; Wei D; Yap Y; Chen F
Trends Biotechnol; 2007 Apr; 25(4):166-73. PubMed ID: 17316853
[TBL] [Abstract][Full Text] [Related]
36. MicroRNAs are novel biomarkers of colorectal cancer.
Aslam MI; Taylor K; Pringle JH; Jameson JS
Br J Surg; 2009 Jul; 96(7):702-10. PubMed ID: 19526617
[TBL] [Abstract][Full Text] [Related]
37. Microarray and histopathological analysis of tumours: the future and the past?
Lakhani SR; Ashworth A
Nat Rev Cancer; 2001 Nov; 1(2):151-7. PubMed ID: 11905806
[TBL] [Abstract][Full Text] [Related]
38. Cancer proteomics: many technologies, one goal.
Conrads TP; Hood BL; Petricoin EF; Liotta LA; Veenstra TD
Expert Rev Proteomics; 2005 Oct; 2(5):693-703. PubMed ID: 16209649
[TBL] [Abstract][Full Text] [Related]
39. The application of genomic and proteomic technologies in predictive, preventive and personalized medicine.
Collins CD; Purohit S; Podolsky RH; Zhao HS; Schatz D; Eckenrode SE; Yang P; Hopkins D; Muir A; Hoffman M; McIndoe RA; Rewers M; She JX
Vascul Pharmacol; 2006 Nov; 45(5):258-67. PubMed ID: 17030152
[TBL] [Abstract][Full Text] [Related]
40. Antibody arrays--an emerging tool in cancer proteomics.
Kopf E; Zharhary D
Int J Biochem Cell Biol; 2007; 39(7-8):1305-17. PubMed ID: 17600752
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
